Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

HealthCare Royalty Partners

Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 20
Average round size
The average size of a deal this fund participated in
Portfolio companies 13
Rounds per year 1.33
Lead investments 8
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 8
Key employees 7
Stages of investment
Private Equity

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Therapeutics

HealthCare Royalty Partners appeared to be the VC, which was created in 2007. The leading representative office of defined VC is situated in the Stamford. The company was established in North America in United States.

Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this HealthCare Royalty Partners performs on 0 percentage points less the average number of lead investments. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2017. The high activity for fund was in 2014. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations.

We can highlight the next thriving fund investment areas, such as Health Care, Biopharma. Among the most popular portfolio startups of the fund, we may highlight AcuFocus, Nuron Biotech, Cardiorentis. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups.

The overall number of key employees were 6.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the HealthCare Royalty Partners, startups are often financed by Quaker BioVentures, Kleiner Perkins, Helix Ventures. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, Valence Life Sciences, The Carlyle Group. In the next rounds fund is usually obtained by SV Health Investors, Essex Woodlands Healthcare Partners, Wellington Management.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of HealthCare Royalty Partners:
Typical Co-investors
HealthCare Royalty Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after HealthCare Royalty Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accuitive Medical Ventures Duluth, Georgia, United States
ATW Partners New York, New York, United States
Ding Jing Wang Beijing, China, Haidian
Dongguanshi Rongke Touzi China, Dongguang, Guangdong
Envision Capital Management California, Los Angeles, United States
Genesis Inventions, L.P. Austin, Texas, United States
Guohua Taifeng Touzi China, Ürümqi, Xinjiang
Incubate Fund India Bengaluru, India, Karnataka
IndustrialVortex -
Invitation Homes Dallas, Texas, United States
MI8 -
PortfoLion Budapest, Hungary
PSA Group France, Ile-de-France, Paris
Siam Cement Group Bangkok, Krung Thep, Thailand
Sierra Angels Incline Village, Nevada, United States
Sierra Wireless Canada, Ontario, Richmond Hill
Tsuneishi Partners Japan, Kurayoshi, Tottori Prefecture
Tuniu China, Jiangsu, Nanjing
Weltbild Augsburg, Bayern, Germany

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
$20M30 Jun 2022 Fremont, California, United States

Rhythm Pharmaceuticals

$37M16 Jun 2022 Boston, Massachusetts, United States

Spero Therapeutics

Medical Device
$125M30 Sep 2021 Cambridge, Massachusetts, United States

Portola Pharmaceuticals

$125M04 Mar 2019 South San Francisco, California, United States

Coherus Biosciences

Health Care
$75M08 Jan 2019 Redwood City, California, United States


Clinical Trials
Health Care
Medical Device
$19M14 Apr 2016 North Carolina, United States


Health Care
Medical Device
$22M13 Feb 2015 San Francisco, California, United States


Health Care
Health Diagnostics
$60M13 Nov 2014 Pittsburgh, Pennsylvania, United States


Health Care
$53M18 Sep 2014 Zug, Switzerland


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent HealthCare Royalty Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: